Chemours
CC | NYSE
$13.53
+$0.34 (+2.58%)
At close: Oct 30, 2026, 3:59 PM ET
$13.66
+$0.13 (+0.96%)
Pre-market:
Nov 2, 2026, 7:00 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Net Income | -386M | 86M | -238M | 578M | 608M | 219M |
Depreciation & Amortization | 340M | 301M | 307M | 291M | 317M | 320M |
Stock-Based Compensation | 21M | 15M | 19M | 27M | 34M | 16M |
Other Working Capital | 343M | -745M | 634M | -5M | 175M | 163M |
Other Non-Cash Items | 47M | 44M | 6M | -58M | -89M | 16M |
Deferred Income Tax | 64M | -27M | -158M | 20M | -77M | -120M |
Change in Working Capital | 178M | -1.05B | 620M | -103M | 21M | 356M |
Operating Cash Flow | 264M | -633M | 556M | 755M | 814M | 807M |
Capital Expenditures | -213M | -360M | -370M | -307M | -277M | -267M |
Cash Acquisitions | 7M | n/a | n/a | n/a | n/a | 5M |
Purchase of Investments | n/a | n/a | n/a | n/a | -12M | -5M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | 27M |
Other Investing Acitivies | n/a | 7M | 141M | 23M | 509M | 6M |
Investing Cash Flow | -206M | -353M | -229M | -284M | 220M | -234M |
Debt Repayment | -61M | 95M | 393M | -80M | -208M | -149M |
Common Stock Repurchased | -1M | n/a | -69M | -495M | -173M | -2M |
Dividend Paid | -78M | -148M | -149M | -154M | -164M | -164M |
Other Financial Acitivies | 14M | 8M | 16M | 43M | -9M | -134M |
Financial Cash Flow | -126M | -36M | 172M | -686M | -554M | -449M |
Net Cash Flow | -41M | -1.04B | 503M | -247M | 446M | 162M |
Free Cash Flow | 51M | -993M | 186M | 448M | 537M | 540M |
Adj. Free Cash Flow | 30M | -1.01B | 167M | 421M | 503M | 524M |
Maintenance CapEx | -197.51M | -360M | -370M | -35.09M | n/a | -267M |
Growth CapEx | -15.49M | n/a | n/a | -271.91M | -277M | n/a |
Owner Earnings | 66.49M | -993M | 186M | 719.91M | 814M | 540M |
Add to Watchlist
Select watchlists to add or remove CC